| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.6 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.7 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |